CDC20 and colorectal carcinoma: Furthermore, the survival analysis of hub genes showed that overexpression of CDK1 and CDC20 were associated with poor survival in patients with CRC, suggesting that CDK1 and CDC20 may have potential as biomarker for CRC diagnosis, treatment, or prognosis determination.